90 related articles for article (PubMed ID: 25907066)
1. Soluble Expression and Purification of the Catalytic Domain of Human Vascular Endothelial Growth Factor Receptor 2 in Escherichia coli.
Wei J; Cao X; Zhou S; Chen C; Yu H; Zhou Y; Wang P
J Microbiol Biotechnol; 2015 Aug; 25(8):1227-33. PubMed ID: 25907066
[TBL] [Abstract][Full Text] [Related]
2. [Cloning, expression and purification of KDR tyrosine kinase].
Liu C; Zhang Y; Li Y
Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1545-9. PubMed ID: 19160835
[TBL] [Abstract][Full Text] [Related]
3. Expression and purification of human vascular-endothelial-growth-factor-receptor-2 tyrosine kinase in Streptomyces for inhibitor screening.
Liu C; Guo L; Yao C; Zhang R; Li Y
Biotechnol Appl Biochem; 2008 Jun; 50(Pt 2):113-9. PubMed ID: 17824843
[TBL] [Abstract][Full Text] [Related]
4. Expression and purification of the catalytic domain of human vascular endothelial growth factor receptor 2 for inhibitor screening.
Zhong L; Guo XN; Zhang XH; Wu ZX; Luo XM; Jiang HL; Lin LP; Zhang XW; Ding J
Biochim Biophys Acta; 2005 Apr; 1722(3):254-61. PubMed ID: 15715968
[TBL] [Abstract][Full Text] [Related]
5. Preparation of extracellular domain 3 of human VEGF receptor-2 and the monitoring of its real-time binding to VEGF by biosensors.
Zhang J; Li H; Chen W; Cao P; Wang M
Biotechnol Prog; 2009; 25(6):1703-8. PubMed ID: 19731341
[TBL] [Abstract][Full Text] [Related]
6. [Expression and function identification of extracellular domain 3 of human vascular endothelial growth factor receptor KDR].
Zhang J; Zhang Y; Li H; Chen W; Zhang T; Wang M
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1962-7. PubMed ID: 19256346
[TBL] [Abstract][Full Text] [Related]
7. The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain.
Li H; Cao W; Chen Z; Acheampong DO; Jin H; Li D; Zhang J; Wang M
Biomed Pharmacother; 2013 Sep; 67(7):599-606. PubMed ID: 23906761
[TBL] [Abstract][Full Text] [Related]
8. Development of an AlphaScreen-based high-throughput screening assay for inhibitors of human vascular endothelial growth factor receptor-3.
Wang K; Yang R; Xu J; Zhang Y; Zhu L; Lin J; Huang B
J Immunoassay Immunochem; 2011; 32(3):219-32. PubMed ID: 21574093
[TBL] [Abstract][Full Text] [Related]
9. Characterization and development of a peptide substrate-based phosphate transfer assay for the human vascular endothelial growth factor receptor-2 tyrosine kinase.
Zhao G; Peery RB; Yingling JM
Anal Biochem; 2007 Jan; 360(2):196-206. PubMed ID: 17141171
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and Conformational Characterization of Recombinant VEGFR2 Domain 7.
Di Stasi R; Diana D; De Rosa L; Fattorusso R; D'Andrea LD
Mol Biotechnol; 2019 Nov; 61(11):860-872. PubMed ID: 31531759
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2.
Erdag B; Balcioglu BK; Bahadir AO; Serhatli M; Kacar O; Bahar A; Seker UO; Akgun E; Ozkan A; Kilic T; Tamerler C; Baysal K
Biotechnol Appl Biochem; 2011; 58(6):412-22. PubMed ID: 22172104
[TBL] [Abstract][Full Text] [Related]
12. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
13. A new model for random screening inhibitors of vascular endothelial growth factor receptor 1 kinase.
Zhuang SF; Zhou CH; Qian J; Qian Z; Shibuya M; Ye QZ
Acta Pharmacol Sin; 2002 Feb; 23(2):117-23. PubMed ID: 11866870
[TBL] [Abstract][Full Text] [Related]
14. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
15. Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts.
Davis DW; Inoue K; Dinney CP; Hicklin DJ; Abbruzzese JL; McConkey DJ
Cancer Res; 2004 Jul; 64(13):4601-10. PubMed ID: 15231672
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.
Beebe JS; Jani JP; Knauth E; Goodwin P; Higdon C; Rossi AM; Emerson E; Finkelstein M; Floyd E; Harriman S; Atherton J; Hillerman S; Soderstrom C; Kou K; Gant T; Noe MC; Foster B; Rastinejad F; Marx MA; Schaeffer T; Whalen PM; Roberts WG
Cancer Res; 2003 Nov; 63(21):7301-9. PubMed ID: 14612527
[TBL] [Abstract][Full Text] [Related]
17. Targeting expression of the catalytic domain of the kinase insert domain receptor (KDR) in the peroxisomes of Pichia pastoris.
Wang Y; Xuan Y; Zhang P; Jiang X; Ni Z; Tong L; Zhou X; Lin L; Ding J; Zhang Y
FEMS Yeast Res; 2009 Aug; 9(5):732-41. PubMed ID: 19473276
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
Wu J; Strawn TL; Luo M; Wang L; Li R; Ren M; Xia J; Zhang Z; Ma W; Luo T; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):111-20. PubMed ID: 25378411
[TBL] [Abstract][Full Text] [Related]
19. [Prokaryotic expression, purification and identification of VEGFR2 D3.4/GST fusion protein in E.coli].
Wei YY; Song CJ; Sun YJ; Gong JY; Jin BQ; Yang AG; Yang K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):870-2. PubMed ID: 18782519
[TBL] [Abstract][Full Text] [Related]
20. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
